PLGA nanoparticles loaded with miR-30b-5p can improve cardiac function, attenuate myocardial injury, and regulate the expression of factors associated with cardiac hypertrophy and inflammation by targeting TGFBR2 [28]. Here, TGFBR2 is linked to cardiac hypertrophy.